Back to Search Start Over

Comparison of Isomerase and Weimberg Pathway for γ-PGA Production From Xylose by Engineered Bacillus subtilis .

Authors :
Halmschlag B
Hoffmann K
Hanke R
Putri SP
Fukusaki E
Büchs J
Blank LM
Source :
Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2020 Jan 21; Vol. 7, pp. 476. Date of Electronic Publication: 2020 Jan 21 (Print Publication: 2019).
Publication Year :
2020

Abstract

The production of poly-γ-glutamic acid (γ-PGA), a biopolymer consisting of D- and L-glutamic acid monomers, currently relies on L-glutamate, or citrate as carbon substrates. Here we aimed at using plant biomass-derived substrates such as xylose. γ-PGA producing microorganisms including Bacillus subtilis natively metabolize xylose via the isomerase pathway. The Weimberg pathway, a xylose utilization pathway first described for Caulobacter crescentus , offers a carbon-efficient alternative converting xylose to 2-oxoglutarate without carbon loss. We engineered a recombinant B. subtilis strain that was able to grow on xylose with a growth rate of 0.43 h <superscript>-1</superscript> using a recombinant Weimberg pathway. Although ion-pair reversed-phase LC/MS/MS metabolome analysis revealed lower concentrations of γ-PGA precursors such as 2-oxoglutarate, the γ-PGA titer was increased 6-fold compared to the native xylose isomerase strain. Further metabolome analysis indicates a metabolic bottleneck in the phosphoenolpyruvate-pyruvate-oxaloacetate node causing bi-phasic (diauxic) growth of the recombinant Weimberg strain. Flux balance analysis (FBA) of the γ-PGA producing B. subtilis indicated that a maximal theoretical γ-PGA yield is achieved on D-xylose/ D-glucose mixtures. The results of the B. subtilis strain harboring the Weimberg pathway on such D-xylose/ D-glucose mixtures demonstrate indeed resource efficient, high yield γ-PGA production from biomass-derived substrates.<br /> (Copyright © 2020 Halmschlag, Hoffmann, Hanke, Putri, Fukusaki, Büchs and Blank.)

Details

Language :
English
ISSN :
2296-4185
Volume :
7
Database :
MEDLINE
Journal :
Frontiers in bioengineering and biotechnology
Publication Type :
Academic Journal
Accession number :
32039180
Full Text :
https://doi.org/10.3389/fbioe.2019.00476